Long Noncoding RNA FOXP4-AS1 Predicts Unfavourable Prognosis and Regulates Proliferation and Invasion in Hepatocellular Carcinoma

Figure 1

Expression of FOXP4-AS1 in HCC and its correlation with clinical outcome. Patients were divided into groups based on the difference of FOXP4-AS1 expression between HCC and adjacent normal tissues: (a) training set, (b) validation set, and (c) combined set. Compared with adjacent nontumor tissues, the FOXP4-AS1 expression was downregulated in the training set (d), validation set (e), and combination set (f) using the qRT-PCR assay. The DFS and OS of HCC patients with high or low FOXP4-AS1 expression in the training set (; (g), (j), validation set (n =34; (h), (k)) and combined set (; (i), (l)) were compared by the Kaplan-Meier survival analysis.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)